Market Exclusive

Analyst Upgrades – NASDAQ:PRTO – Proteon Therapeutics (NASDAQ:PRTO) Stock Gets Upgraded By HC Wainwright from Neutral ➝ Buy to

Analyst Ratings For NASDAQ:PRTO – Proteon Therapeutics (NASDAQ:PRTO)

Today, NASDAQ:PRTO – Proteon Therapeutics (NASDAQ:PRTO) stock received an upgrade by HC Wainwright from Neutral ➝ Buy with a price target of $3.00.

Some recent analyst ratings include

Recent Insider Trading Activity For NASDAQ:PRTO – Proteon Therapeutics (NASDAQ:PRTO)
NASDAQ:PRTO – Proteon Therapeutics (NASDAQ:PRTO) has insider ownership of 45.70% and institutional ownership of 50.18%.

Recent Trading Activity for NASDAQ:PRTO – Proteon Therapeutics (NASDAQ:PRTO)
Shares of NASDAQ:PRTO – Proteon Therapeutics closed the previous trading session at 2.13 up +0.03 1.43% with shares trading hands.

Exit mobile version